KAMI MARTIN: Open Payments
NPI 1104688506 · MONETT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 37 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $133 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $170 |
| Otsuka America Pharmaceutical, Inc. | 5 | $92 |
| Lilly USA, LLC | 3 | $62 |
| PFIZER INC. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Exact Sciences Corporation | 3 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 1 | $36 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Abbott Laboratories | 1 | $20 |
Products named: VRAYLAR, REXULTI, MOUNJARO, CAPLYTA, UBRELVY, BREZTRI, FANAPT, Cologuard Collection Kit.
Industry payments across MO — which companies pay providers there.
